Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis.
暂无分享,去创建一个
R. Selgas | T. Bellón | M. Bajo | L. Aroeira | M. Castro | M. Ossorio | R. Sánchez-Villanueva | V. Martínez | B. Lucendo | Aranzazu Rodríguez-Sanz | G. Del Peso
[1] E. Brown,et al. CCL18 in peritoneal dialysis patients and encapsulating peritoneal sclerosis , 2010, European journal of clinical investigation.
[2] M. Olschewski,et al. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.
[3] J. Edwards,et al. Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.
[4] M. Lam,et al. Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[5] R. Geffers,et al. Gene Expression Profiling of Human Decidual Macrophages: Evidence for Immunosuppressive Phenotype , 2008, PloS one.
[6] S. John,et al. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages , 2007, Proceedings of the National Academy of Sciences.
[7] M. Röllinghoff,et al. Expression and regulation of CCL18 in synovial fluid neutrophils of patients with rheumatoid arthritis , 2007, Arthritis research & therapy.
[8] J. Jimenez-Heffernan,et al. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. , 2007, Journal of the American Society of Nephrology : JASN.
[9] T. K. van den Berg,et al. Human peritoneal macrophages show functional characteristics of M‐CSF‐driven anti‐inflammatory type 2 macrophages , 2007, European journal of immunology.
[10] A. Prasse,et al. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. , 2007, Arthritis and rheumatism.
[11] A. Sica,et al. New vistas on macrophage differentiation and activation , 2007, European journal of immunology.
[12] M. Garcia-Blanco,et al. Human Transcription Elongation Factor CA150 Localizes to Splicing Factor-Rich Nuclear Speckles and Assembles Transcription and Splicing Components into Complexes through Its Amino and Carboxyl Regions , 2006, Molecular and Cellular Biology.
[13] Antje Prasse,et al. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. , 2006, American journal of respiratory and critical care medicine.
[14] So-Jung Gwak,et al. Skin regeneration using keratinocytes and dermal fibroblasts cultured on biodegradable microspherical polymer scaffolds. , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.
[15] J. Van Damme,et al. Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes , 2005, Journal of leukocyte biology.
[16] J. Suttles,et al. Macrophages Sequentially Change Their Functional Phenotype in Response to Changes in Microenvironmental Influences1 , 2005, The Journal of Immunology.
[17] S. Forbes,et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. , 2005, The Journal of clinical investigation.
[18] T. Bellón,et al. Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j. , 2004, Biochemical and biophysical research communications.
[19] T. Wynn. Fibrotic disease and the TH1/TH2 paradigm , 2004, Nature Reviews Immunology.
[20] N. Longo,et al. Regulated Expression of the Pathogen Receptor Dendritic Cell-specific Intercellular Adhesion Molecule 3 (ICAM-3)-grabbing Nonintegrin in THP-1 Human Leukemic Cells, Monocytes, and Macrophages* , 2004, Journal of Biological Chemistry.
[21] P. De Baetselier,et al. Alternatively activated macrophages during parasite infections. , 2004, Trends in parasitology.
[22] M. Miyazaki,et al. CCL17 and IL-10 as Effectors That Enable Alternatively Activated Macrophages to Inhibit the Generation of Classically Activated Macrophages1 , 2004, The Journal of Immunology.
[23] P. Bonniaud,et al. Basic Mechanisms and Clinical Implications of Peritoneal Fibrosis , 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[24] A. Yang,et al. Myofibroblastic conversion of mesothelial cells. , 2003, Kidney international.
[25] T. Geijtenbeek,et al. Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. , 2003, The American journal of pathology.
[26] J. Jimenez-Heffernan,et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. , 2003, The New England journal of medicine.
[27] P. Allavena,et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.
[28] D. Reen,et al. Lipopolysaccharide Induces Rapid Production of IL-10 by Monocytes in the Presence of Apoptotic Neutrophils1 , 2002, The Journal of Immunology.
[29] Robert Coffman,et al. CCL18/DC‐CK‐1/PARC up‐regulation in hypersensitivity pneumonitis , 2001, Journal of leukocyte biology.
[30] R. Homer,et al. Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1 , 2001, The Journal of experimental medicine.
[31] K. Nitta,et al. Identification of T Helper Cell Subsets in Continuous Ambulatory Peritoneal Dialysis Patients , 2001, Nephron.
[32] S. Goerdt,et al. Alternatively Activated Macrophages Differentially Express Fibronectin and Its Splice Variants and the Extracellular Matrix Protein βIG‐H3 , 2001, Scandinavian journal of immunology.
[33] Bengt Rippe,et al. Evaluation and Management of Ultrafiltration Problems in Peritoneal Dialysis , 2000 .
[34] B. Antus,et al. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. , 2000, Cellular immunology.
[35] I. Stamenkovic,et al. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. , 2000, Genes & development.
[36] B. Hylander,et al. Increased Levels of Transforming Growth Factor β1 and Basic Fibroblast Growth Factor in Patients on CAPD: A Study During Non-Infected Steady State and Peritonitis , 1999, Inflammation.
[37] S. Goerdt,et al. Other functions, other genes: alternative activation of antigen-presenting cells. , 1999, Immunity.
[38] P. Högger,et al. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). , 1998, Journal of immunology.
[39] V. Fadok,et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. , 1998, The Journal of clinical investigation.
[40] S. Goerdt,et al. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. , 1998, Journal of immunology.
[41] S. Goerdt,et al. Differences in angiogenic potential of classically vs alternatively activated macrophages. , 1997, Immunobiology.
[42] T. Mcclanahan,et al. A dendritic-cell-derived C–C chemokine that preferentially attracts naive T cells , 1997, Nature.
[43] J. Lindeman,et al. Monoclonal antibodies against the human mannose receptor as a specific marker in flow cytometry and immunohistochemistry for macrophages , 1997, Journal of leukocyte biology.
[44] B. Hylander,et al. Interleukin-10, Interferon Gamma, Interleukin-2, and Soluble Interleukin-2 Receptor Alpha Detected during Peritonitis in the Dialysate and Serum of Patients on Continuous Ambulatory Peritoneal Dialysis , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[45] S. Wahl,et al. Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[46] S Gordon,et al. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation , 1992, The Journal of experimental medicine.
[47] R. Geha,et al. Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes , 1988, The Journal of experimental medicine.
[48] Alberto Mantovani,et al. Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.
[49] S. Gordon. Alternative activation of macrophages , 2003, Nature Reviews Immunology.
[50] R. Selgas,et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[51] R. Krediet. The peritoneal membrane in chronic peritoneal dialysis. , 1999, Kidney international.
[52] R. Selgas,et al. Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.